Statin Therapy
AACE guidance examines medication options for preventing ASCVD in adults with dyslipidemia
Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting newer medications that could be added to statin therapy or used on patients intolerant to statins.
Wegovy may reduce need for antihypertensive, lipid-lowering therapies
Adults receiving semaglutide for the treatment of obesity were more likely to have antihypertensive or lipid-lowering therapy tapered or discontinued than those receiving placebo, according to data from the STEP trials.
Having three or more metabolic risk factors raises diabetes risk in people with HIV
In adults living with HIV, those with three or more metabolic risk factors had a higher risk for developing new-onset diabetes than those without any risk factors, according to new findings from the REPRIEVE trial.
Fruits and vegetables ‘foundational management’ for treating hypertension
Dietary acid reduction from fruits and vegetables or sodium bicarbonate improved kidney health in patients with hypertension and macroalbuminuria, findings from a randomized controlled trial showed.
Top in cardiology: AHA calculator may reduce care eligibility; predicting atherosclerosis
An estimated 16 million U.S. adults who qualified for statin and/or antihypertensive therapy would not be eligible for primary prevention under the American Heart Association’s new PREVENT risk calculator, researchers reported in JAMA.
New risk calculator could reduce eligibility for statins, BP drugs by 16 million US adults
Using the American Heart Association’s new PREVENT risk calculator would mean reducing eligibility for statin and/or antihypertensive therapy by approximately 16 million U.S. adults, researchers reported in JAMA.